Your browser doesn't support javascript.
Prevalence of cardiovascular diseases in COVID-19 related mortality in the United States.
Vasudeva, Rhythm; Challa, Abhiram; Al Rifai, Mahmoud; Polana, Tejasri; Duran, Brent; Vindhyal, Mohinder; Lewis, Eldrin F.
  • Vasudeva R; Department of Internal Medicine, University of Kansas School of Medicine, Wichita, KS, USA. Electronic address: rvasudeva@kumc.edu.
  • Challa A; Department of Internal Medicine, University of Kansas School of Medicine, Wichita, KS, USA.
  • Al Rifai M; Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Polana T; School of Medicine, Jawaharlal Nehru Medical College, India.
  • Duran B; Department of Internal Medicine, University of Kansas School of Medicine, Wichita, KS, USA.
  • Vindhyal M; Department of Cardiology, University of Kansas Medical Center, Kansas City, KS, USA.
  • Lewis EF; Department of Cardiovascular Medicine, Stanford University, Stanford, CA, USA.
Prog Cardiovasc Dis ; 74: 122-126, 2022.
Article in English | MEDLINE | ID: covidwho-2082465
ABSTRACT

BACKGROUND:

Several cardiovascular disease (CVD) risk factors and sequelae have been associated with COVID-19. Little is known about the distribution of CVD conditions in COVID-19 related deaths in the US population.

METHODS:

The public-use dataset by CDC, "Conditions Contributing to COVID-19 Deaths, by State and Age, Provisional 2020-2021", was abstracted as of August 1, 2021. A descriptive analysis was conducted to explore the overall and age-specific prevalence of various CVD and risk factors grouped by pre-specified ICD-10 codes amongst COVID-19 patient deaths. Respective trends over the duration of the pandemic were analyzed using the Mann-Kendall method, including time-periods before and after the introduction of vaccines in January 2021. All time-related analysis was conducted between March 2020 and June 2021.

RESULTS:

A total of 600,241 COVID-19 related deaths were reported between March 2020 and June 2021. Hypertensive diseases were the most prevalent (19.6%), followed by diabetes (15.9%), ischemic heart disease (IHD;10.9%), heart failure (7.7%), cardiac arrhythmias (7.5%), other diseases of the circulatory system (6.6%), cerebrovascular diseases (5%), and obesity (4.1%). While a significant downward trend was noted for hypertensive diseases over the course of the pandemic, cardiac arrhythmias, heart failure (HF), obesity, and other circulatory system diseases demonstrated a significant upward trend. Since the introduction of vaccines, the trends for heart failure and cardiac arrhythmias remained steady while having demonstrated a significant rise in the pre-vaccination time-period. While obesity and other diseases of the circulatory system predominated (>50%) amongst the CVD burden in the younger population (0-24 years and 25-34 years), the percentage occurrence of cardiac arrhythmias, hypertensive diseases, HF, and IHD increased with age.

CONCLUSION:

Hypertensive diseases, diabetes, and IHD were the most prevalent cardiovascular conditions amongst COVID-19 related deaths. These patterns varied by age. While the trend for hypertensive diseases declined over the course of the pandemic, cardiac arrhythmias, HF, obesity, and other diseases of the circulatory system demonstrated an upward trend. An important limitation is the source of the data being limited to death certificates.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cardiovascular Diseases / COVID-19 / Heart Failure Type of study: Experimental Studies / Observational study / Prognostic study Topics: Long Covid / Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: Prog Cardiovasc Dis Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Cardiovascular Diseases / COVID-19 / Heart Failure Type of study: Experimental Studies / Observational study / Prognostic study Topics: Long Covid / Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: Prog Cardiovasc Dis Year: 2022 Document Type: Article